losartan has been researched along with urea in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (13.33) | 18.2507 |
| 2000's | 2 (13.33) | 29.6817 |
| 2010's | 10 (66.67) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Avdeef, A; Tam, KY | 1 |
| Ferrari-Spadotto, A; Franco, R; Gavras, H; Gavras, I; Georgette, J; Gut, A | 1 |
| Heller, J; Horácek, V; Kramer, HJ | 1 |
| Cervenka, L; Havlícková, J; Heller, J; Spatenka, J | 1 |
| Jovović, D; Mihailović-Stanojević, N; Milanović, JG; Milanović, S; Miloradović, Z | 1 |
| Grujic Milanovic, J; Ivanov, M; Jovovic, D; Mihailovic-Stanojevic, N; Miloradovic, Z | 1 |
| Adem, A; Ali, MA; Benedict, S; Chandranath, IS; Frampton, CM; Kazzam, E; Lewis, LK; Nagelkerke, N; Nicholls, GM; Nyberg, F; Pathan, JY; Yandle, TG | 1 |
| Ćirović, S; Grujić Milanović, J; Ivanov, M; Jovović, Đ; Marković-Lipkovski, J; Mihailović-Stanojević, N; Miloradović, Z | 1 |
| Gong, XZ; Lu, L; Qian, YR; Tang, XC; Wang, Q; Wang, YR; Zhou, JJ; Zhou, LF | 1 |
| Daneshtalab, N; Smeda, JS | 1 |
| Abd-Eldayem, AM; Abdel-Zaher, AO; El-Refaiy, AEM; Farghaly, HSM | 1 |
| Arellano Buendía, AS; Arguello García, R; García Arroyo, FE; García Trejo, EMÁ; Loredo Mendoza, ML; Osorio Alonso, H; Sánchez Lozada, LG; Sánchez Reyes, O; Tapia, E | 1 |
| Ebrahimzadeh Bideskan, A; Hosseinian, S; Khajavi Rad, A; Sadeghnia, HR; Samadi Noshahr, Z; Shafei, MN; Shahraki, S; Soukhtanloo, M | 1 |
| da Silva Sólon, LG; Martin-Pastor, M; Queiroz, KA; Santos, ISR; Sousa, FFO; Tavares Júnior, AG | 1 |
1 trial(s) available for losartan and urea
| Article | Year |
|---|---|
[Effect of Chuanhuang No. 1 recipe on renal function and micro-inflammation in phase 3 chronic kidney disease patients].
Topics: Adult; Blood Urea Nitrogen; C-Reactive Protein; Drugs, Chinese Herbal; Female; Humans; Inflammation; Interleukin-6; Losartan; Male; Middle Aged; Phytotherapy; Renal Insufficiency, Chronic; Tumor Necrosis Factor-alpha; Urea | 2015 |
14 other study(ies) available for losartan and urea
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological; Permeability; Porosity; Regression Analysis | 2010 |
Pressor mechanisms in adriamycin-induced nephropathy with hypertension in rats.
Topics: Angiotensin II; Animals; Biphenyl Compounds; Blood Pressure; Cholesterol; Creatinine; Doxorubicin; Hypertension; Imidazoles; Kidney; Kidney Failure, Chronic; Losartan; Male; Nephrotic Syndrome; Potassium; Rats; Rats, Wistar; Serum Albumin; Sodium; Tetrazoles; Time Factors; Urea; Vasopressins | 1994 |
Comparative effects of the angiotensin II receptor blocker EXP 3174 and of the angiotensin-converting enzyme inhibitor captopril on renal glomerular hemodynamics in the dog.
Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Flow Velocity; Blood Pressure; Bradykinin; Captopril; Dogs; Drug Combinations; Female; Glomerular Filtration Rate; Imidazoles; Kidney Glomerulus; Losartan; Male; Potassium; Sodium; Tetrazoles; Urea; Vascular Resistance; Vasodilation; Water | 1997 |
[Experimental ischemic renal injury--effect of surgical technique and the protective effect of a nonpeptide angiotensin II antagonist (losartan)].
Topics: Angiotensin II; Animals; Creatinine; Ischemia; Kidney; Losartan; Male; Protective Agents; Rats; Rats, Wistar; Time Factors; Urea | 2000 |
Effects of long-term losartan and L-arginine treatment on haemodynamics, glomerular filtration, and SOD activity in spontaneously hypertensive rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Aorta, Abdominal; Arginine; Blood Pressure; Carotid Arteries; Disease Models, Animal; Drug Therapy, Combination; Glomerular Filtration Rate; Hemodynamics; Hypertension; Kidney; Losartan; Male; Nitric Oxide Donors; Rats; Rats, Inbred SHR; Regional Blood Flow; Renal Artery; Renal Circulation; Superoxide Dismutase; Time Factors; Urea; Vascular Resistance | 2008 |
Prevention of systemic and regional haemodynamic alterations, hypercreatininemia, hyperuremia and hyperphosphatemia by losartan in hypertension with acute renal failure.
Topics: Acute Kidney Injury; Angiotensin II Type 1 Receptor Blockers; Animals; Creatinine; Hemodynamics; Hyperphosphatemia; Hypertension; Losartan; Male; Random Allocation; Rats; Rats, Inbred SHR; Renal Circulation; Urea | 2011 |
Responses to dehydration in the one-humped camel and effects of blocking the renin-angiotensin system.
Topics: Aldosterone; Analysis of Variance; Animals; Arginine Vasopressin; Body Weights and Measures; Camelus; Creatinine; Dehydration; Losartan; Male; Renin-Angiotensin System; Sodium; United Arab Emirates; Urea | 2012 |
Losartan improved antioxidant defense, renal function and structure of postischemic hypertensive kidney.
Topics: Angiotensin Receptor Antagonists; Animals; Antioxidants; bcl-2-Associated X Protein; Catalase; Cholesterol, LDL; Creatinine; Down-Regulation; Kidney; Kidney Function Tests; Lipid Peroxidation; Losartan; Male; Oxidative Stress; Rats, Inbred SHR; Reperfusion Injury; Urea | 2014 |
Cerebrovascular recovery after stroke with individual and combined losartan and captopril treatment of SHRsp.
Topics: Aldosterone; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Cerebrovascular Circulation; Disease Models, Animal; Drug Combinations; Enzyme Activation; Hypertension; Infarction, Middle Cerebral Artery; Losartan; Middle Cerebral Artery; Nitric Oxide; Protein Kinase C; Rats, Inbred SHR; Rats, Inbred WKY; Renin-Angiotensin System; Time Factors; Urea; Uric Acid; Vasoconstriction | 2017 |
Protective effect of the standardized extract of ginkgo biloba (EGb761) against hypertension with hypercholesterolemia-induced renal injury in rats: Insights in the underlying mechanisms.
Topics: Animals; Blood Pressure; Creatinine; Diastole; Ginkgo biloba; Glutathione; Hypercholesterolemia; Hypertension; Kidney; Lipids; Losartan; Male; Malondialdehyde; Nitric Oxide Synthase Type III; Nitrites; Plant Extracts; Protective Agents; Rats, Wistar; Simvastatin; Systole; Urea | 2017 |
The Beneficial Effects of Allicin in Chronic Kidney Disease Are Comparable to Losartan.
Topics: Acetylglucosaminidase; Animals; Antihypertensive Agents; Antioxidants; Creatinine; Disulfides; Kelch-Like ECH-Associated Protein 1; Kidney; Losartan; Male; Membrane Proteins; Nitric Oxide Synthase Type III; Oxidative Stress; Rats; Rats, Wistar; Receptors, Angiotensin; Renal Insufficiency, Chronic; Sulfinic Acids; Urea | 2017 |
Nigella sativa extract is a potent therapeutic agent for renal inflammation, apoptosis, and oxidative stress in a rat model of unilateral ureteral obstruction.
Topics: Angiotensin II; Animals; Apoptosis; Captopril; Chemokine CCL2; Creatinine; Fibrosis; Inflammation; Kidney; Kidney Diseases; Losartan; Male; Malondialdehyde; Nigella sativa; Oxidative Stress; Plant Extracts; Rats; Rats, Wistar; Renin-Angiotensin System; Tumor Necrosis Factor-alpha; Urea; Ureteral Obstruction | 2018 |
Metabolomic Profile and Its Correlation with the Plasmatic Levels of Losartan, EXP3174 and Blood Pressure Control in Hypertensive and Chronic Kidney Disease Patients.
Topics: Antihypertensive Agents; Blood Pressure; Humans; Hypertension; Losartan; Renal Insufficiency, Chronic; Urea | 2023 |